TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Agrenius Lungmedicin AB
Closing information (x1000 NOK)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
684
|
1,078
|
1,083 |
| Financial expenses |
47
|
0
|
1 |
| Earnings before taxes |
61
|
388
|
637 |
| EBITDA |
107
|
102
|
103 |
| Total assets |
3,207
|
3,553
|
3,676 |
| Current assets |
290
|
333
|
331 |
| Current liabilities |
173
|
302
|
336 |
| Equity capital |
2,868
|
3,029
|
3,088 |
| - share capital |
99
|
97
|
101 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
89.4%
|
85.3%
|
84.0% |
| Turnover per employee |
684
|
1,078
|
1,083 |
| Profit as a percentage of turnover |
8.9%
|
36.0%
|
58.8% |
| Return on assets (ROA) |
3.4%
|
10.9%
|
17.4% |
| Current ratio |
167.6%
|
110.3%
|
98.5% |
| Return on equity (ROE) |
2.1%
|
12.8%
|
20.6% |
| Change turnover |
-417
|
34
|
-328 |
| Change turnover % |
-38%
|
3%
|
-23% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.